News | EU Patents Matter

'Internet of things' spurs broad interest in standard essential patent licensing4 Feb 2019
ANALYSIS: A push to set new principles around the licensing of standard-essential patents highlights the growing number of businesses whose operations, products and services now rely on standardised technology.
Biologics and biosimilars: competition law tipped to shape market31 Jan 2019
Manufacturers of biological medicines, or 'biologics', in Europe must consider how competition law might impact the way they market their products and enforce their patent rights throughout the lifetime of their products, experts in intellectual property (IP) and competition law at international law...
Generics closer to gaining new EU manufacturing waiver18 Jan 2019
Plans to give generic drugs companies more freedom to manufacture new medicines in the EU more quickly moved closer to becoming law after they were endorsed by an EU law-making body earlier this week.
Life sciences: beyond Brexit, restructuring and a focus on tech to unlock value in 20198 Jan 2019
ANALYSIS: Brexit concerns will continue to be a boardroom issue for the life sciences sector in 2019, but a focus on corporate restructuring, partnering and greater use of new technologies is likely to drive change and growth in the sector this year.
UK confirms tax relief cap for acquired goodwill3 Jan 2019
Tax relief is to be re-introduced in the UK for goodwill acquired on a business purchase but will be capped at six times the value of intellectual property (IP) assets being purchased, government amendments to the Finance Bill 2019 confirm.
Brexit: businesses urged to accelerate IP registrations15 Nov 2018
Businesses hoping to register new EU trade marks or Community designs should accelerate any pending applications to try to obtain those rights prior to Brexit, an intellectual property (IP) law expert has said.